Cardiac monitoring market expected to reach $26.4 billion by 2029, driven by awareness & prevention efforts.

From GlobeNewswire: 2024-05-21 08:30:00

The Cardiac Monitoring & Cardiac Rhythm Management Devices market is estimated to be worth $21.3 billion in 2024, poised to reach $26.4 billion by 2029, growing at a CAGR of 4.3%. Factors driving growth include rising awareness and prevention initiatives. However, cybersecurity vulnerabilities pose challenges. Segments include ECG Devices, Defibrillators, Pacemakers, with applications in arrhythmias, myocardial infarction, heart failure, and more. Key players include Abbott Laboratories, Medtronic, and Boston Scientific Corporation. North America leads the market due to advanced healthcare infrastructure. The Hospitals segment is expected to dominate the market. Researchers, healthcare providers, and government stakeholders are key players in this industry.



Read more at GlobeNewswire: Cardiac Monitoring & Cardiac Rhythm Management Devices